Zubidox 10 mg Injection

उत्पाद विवरण

Zubidox 10 mg injection is a potent chemotherapy agent utilized in conjunction with other treatments to combat various cancers, including bladder, breast, lung, stomach, and ovarian cancers, as well as Hodgkin's and non-Hodgkin's lymphoma. This medication is also effective against specific types of leukemia, such as acute lymphocytic leukemia (ALL) and acute myeloid leukemia (AML). Additionally, Zubidox may be administered alone or alongside other drugs for the treatment of certain thyroid cancers and soft tissue or bone sarcomas. It is particularly vital in pediatric oncology for conditions like neuroblastoma and Wilms tumor, addressing malignancies that predominantly affect children. The active ingredient, doxorubicin, works by interfering with the growth and reproduction of cancer cells, helping to shrink tumors and improve patient outcomes. Patients receiving Zubidox should be aware of potential side effects, including nausea, hair loss, and increased risk of infection due to its impact on the immune system. Regular monitoring by healthcare professionals is essential to ensure safety and efficacy during treatment. This injectable formulation is a critical component in the fight against various cancers, aiming to enhance survival rates and quality of life for those affected.